Literature DB >> 25828905

HFpEF vs. HFrEF: can microRNAs advance the diagnosis?

Daniela Schmitter1, Adriaan A Voors, Pim van der Harst.   

Abstract

Keywords:  heart failureheart failure with preserved ejection fractionmicroRNAbiomarkerHFpEFdiagnosis

Mesh：

Substances：

Year:  2015        PMID： 25828905     DOI： 10.1002/ejhf.259

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  6 in total

Review 1.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

Review 2.  Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Behrouz Kherad
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 3.  Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.

Authors:  Changhai Tian; Lie Gao; Irving H Zucker
Journal:  Free Radic Biol Med       Date:  2021-03-17       Impact factor: 7.376

Review 4.  The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction.

Authors:  Jerremy Weerts; Sanne G J Mourmans; Arantxa Barandiarán Aizpurua; Blanche L M Schroen; Christian Knackstedt; Etto Eringa; Alfons J H M Houben; Vanessa P M van Empel
Journal:  Biomolecules       Date:  2022-02-09

Review 5.  Role of Different Types of miRNAs in Some Cardiovascular Diseases and Therapy-Based miRNA Strategies: A Mini Review.

Authors:  Safa S Fayez; Sami Mukhlif Mishlish; Hanan M Saied; Semaa A Shaban; Ahmed AbdulJabbar Suleiman; Firas Hassan; Ali Z Al-Saffar; Jameel R Al-Obaidi
Journal:  Biomed Res Int       Date:  2022-09-21       Impact factor: 3.246

6.  Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.

Authors:  Marta Michalska-Kasiczak; Agata Bielecka-Dabrowa; Stephan von Haehling; Stefan D Anker; Jacek Rysz; Maciej Banach
Journal:  Arch Med Sci       Date:  2018-06-11       Impact factor: 3.318
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.